BIOTECHNOLOGY VALUE FUND L P

Holdings History for Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE)

Symbol: GLUE on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 3,835,886 shares
Security Ownership %: 5.9%

BVF PARTNERS L P/IL ownership in Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share (GLUE)

17 Feb 2026 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,835,886 shares of Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share (GLUE). This represents 5.9% ownership of the company. In their previous filing dated 15 May 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 5,660,132 shares, indicating a decrease of +32%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	5.9%	-37%	$92,022,905	3,835,886	-1,824,246	-32%	$23.99	13G/A	31 Dec 2025	17 Feb 2026, 16:14
BVF PARTNERS L P/IL	9.2%	+29%	$29,545,889	5,660,132	+1,266,922	+29%	$5.22	13G/A	31 Mar 2025	15 May 2025, 16:33
BVF PARTNERS L P/IL	7.2%		$22,932,556	4,393,210			$5.22	13G	24 Jan 2025	31 Jan 2025, 18:43